Pioneering Japan Approval For Daiichi’s Oncolytic Virus In Glioma
But Conditions Apply
Japan grants ground-breaking approval for Daiichi oncolytic virus in brain cancer on condition of additional data. The nod marks another step forward in the firm's strategic global pivot to oncology.
You may also be interested in...
Four US senators are leading a bipartisan effort to bring potentially life-saving medical treatments to Medicare beneficiaries by requiring reimbursement for breakthrough technologies cleared by the FDA.
A joint final order from the US Department of Health and Human Services and the Food and Drug Administration says makers of the low-risk gloves must have 510(k) clearance before sending their products to market.
FDA debars Jonathan Doyle for five years from importing food in US due to 2020 conviction through a guilty plea on a felony federal charge. Doyle scheduled for release from prison in September 2022; sentences for some co-defendants end sooner, some later.